30 June-4 July 2018
Amsterdam, the Netherlands
Ed Zijlstra, Senior Consultant, DNDi – session on mycetoma
30 June-4 July 2018
Global Health NOW [1 March 2018]
“The road ahead for the most neglected disease”
Africa Science Gateway [15 February 2018]
“DNDi and partners in new platform to defeat mycetoma”
Global Health NOW [8 February 2018]
“An open pharma approach targets a terrible disease”
IP Watch [7 February 2018]
“New open source drug discovery initiative takes aim at ‘devastating’ disease”
Science & Entreprise [7 February 2018]
“Open-source discovery seeks neglected disease drug”
Computerworld [7 February 2018]
“Researchers look to open source to tackle deadly infection”
Geneva, Rotterdam, Sydney – 6 February 2018
The MycetOS (Mycetoma Open Source) project was launched today by the University of Sydney, Erasmus MC, and DNDi to use an Open Pharma approach to discover compounds that could lead to new treatments for patients suffering from fungal mycetoma (eumycetoma), a devastating disease for which current treatments are ineffective, expensive, and toxic.
The Lancet Global Health Blog [12 January 2018]
“Visualizing an alternative biomedical R&D system”
December 8, 2017
DNDi presented at the event on the NTD Drug Discovery Booster, Chagas disease, and mycetoma.
A l’occasion de l’Evénement économique 2017 du 9 novembre dernier, la Chambre de commerce, d’industrie et des services de Genève (CCIG), le Département de la sécurité et de l’économie (DSE) et l’Office de Promotion des Industries et des Technologies (OPI) ont décerné le Prix 2017 de l’innovation à l’initiative Médicaments contre les Maladies Négligées (DNDi).
As part of the ‘Evénement économique 2017’ that took place on November 9, the Geneva Chamber of Commerce, Industry and Services (CCIG), the Department of Security and Economy (DSE) and the Office for the Promotion of Industries and Technologies (OPI) awarded the Innovation Prize 2017 to the Drugs for Neglected Diseases initiative (DNDi).
DNDi is very pleased to announce the renewed commitment of the Global Health Innovative Technology Fund (GHIT), its donor since 2013, to DNDi projects on leishmaniasis and mycetoma disease
Al-Fanar Media [18 September, 2017]
“Sudan begins to tackle a neglected disease”
Radio Télévision Suisse – CQFD [17 August, 2017]
“La science pour aider les plus démunis: à l’assaut des maladies négligées”
Interview de Bernard Pécoul, Executive Director, DNDi
GHIT Fund [July, 2017]
Stakeholder interviews – Nathalie Strub-Wourgaft”
[Khartoum, Sudan – 19 June 2017]
First ever double-blind study for disease so neglected that it only recently was added to WHO list of neglected tropical diseases
The first-ever double-blind, randomized clinical trial for an effective treatment for the severely neglected disease mycetoma has enrolled its first patient at the Mycetoma Research Centre (MRC) in Khartoum, Sudan.